143 related articles for article (PubMed ID: 20644334)
1. Effects of sulfaphenazole derivatives on cardiac ischemia-reperfusion injury: association of cytochrome P450 activity and infarct size.
Ishihara Y; Sekine M; Hamaguchi A; Kobayashi Y; Harayama T; Nakazawa M; Shimamoto N
J Pharmacol Sci; 2010; 113(4):335-42. PubMed ID: 20644334
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotection by sulfaphenazole, a cytochrome p450 inhibitor: mitigation of ischemia-reperfusion injury by scavenging of reactive oxygen species.
Khan M; Mohan IK; Kutala VK; Kumbala D; Kuppusamy P
J Pharmacol Exp Ther; 2007 Dec; 323(3):813-21. PubMed ID: 17873104
[TBL] [Abstract][Full Text] [Related]
3. Suppression of myocardial ischemia-reperfusion injury by inhibitors of cytochrome P450 in rats.
Ishihara Y; Sekine M; Nakazawa M; Shimamoto N
Eur J Pharmacol; 2009 Jun; 611(1-3):64-71. PubMed ID: 19356728
[TBL] [Abstract][Full Text] [Related]
4. Sulfaphenazole protects heart against ischemia-reperfusion injury and cardiac dysfunction by overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation.
Khan M; Mohan IK; Kutala VK; Kotha SR; Parinandi NL; Hamlin RL; Kuppusamy P
Antioxid Redox Signal; 2009 Apr; 11(4):725-38. PubMed ID: 18855521
[TBL] [Abstract][Full Text] [Related]
5. Sulfaphenazole attenuates myocardial cell apoptosis accompanied with cardiac ischemia-reperfusion by suppressing the expression of BimEL and Noxa.
Ishihara Y; Shimamoto N
J Pharmacol Sci; 2012; 119(3):251-9. PubMed ID: 22785021
[TBL] [Abstract][Full Text] [Related]
6. Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors.
Granville DJ; Tashakkor B; Takeuchi C; Gustafsson AB; Huang C; Sayen MR; Wentworth P; Yeager M; Gottlieb RA
Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1321-6. PubMed ID: 14734800
[TBL] [Abstract][Full Text] [Related]
7. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries.
Fleming I; Michaelis UR; Bredenkötter D; Fisslthaler B; Dehghani F; Brandes RP; Busse R
Circ Res; 2001 Jan; 88(1):44-51. PubMed ID: 11139472
[TBL] [Abstract][Full Text] [Related]
8. [A pathophysiological role of cytochrome p450 involved in production of reactive oxygen species].
Shimamoto N
Yakugaku Zasshi; 2013; 133(4):435-50. PubMed ID: 23546588
[TBL] [Abstract][Full Text] [Related]
9. Cardiomyocyte-restricted overexpression of extracellular superoxide dismutase increases nitric oxide bioavailability and reduces infarct size after ischemia/reperfusion.
Obal D; Dai S; Keith R; Dimova N; Kingery J; Zheng YT; Zweier J; Velayutham M; Prabhu SD; Li Q; Conklin D; Yang D; Bhatnagar A; Bolli R; Rokosh G
Basic Res Cardiol; 2012 Nov; 107(6):305. PubMed ID: 23099819
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction.
Hunter AL; Bai N; Laher I; Granville DJ
Vascul Pharmacol; 2005 Oct; 43(4):213-9. PubMed ID: 16150654
[TBL] [Abstract][Full Text] [Related]
11. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction.
Thummasorn S; Apaijai N; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
Cardiovasc Ther; 2016 Dec; 34(6):404-414. PubMed ID: 27434747
[TBL] [Abstract][Full Text] [Related]
12. Effects of EGb 761 on nitric oxide and oxygen free radicals, myocardial damage and arrhythmia in ischemia-reperfusion injury in vivo.
Shen J; Wang J; Zhao B; Hou J; Gao T; Xin W
Biochim Biophys Acta; 1998 Apr; 1406(3):228-36. PubMed ID: 9630646
[TBL] [Abstract][Full Text] [Related]
13. Effects of sulfaphenazole after collagenase-induced experimental intracerebral hemorrhage in rats.
Hama S; Ishihara Y; Watanabe M; Danjo S; Nakamura Y; Itoh K
Biol Pharm Bull; 2012; 35(10):1849-53. PubMed ID: 23037177
[TBL] [Abstract][Full Text] [Related]
14. Na+/H+ exchanger inhibition at the onset of reperfusion decreases myocardial infarct size: role of reactive oxygen species.
Fantinelli JC; Cingolani HE; Mosca SM
Cardiovasc Pathol; 2006; 15(4):179-84. PubMed ID: 16844548
[TBL] [Abstract][Full Text] [Related]
15. Xanthine oxidase activity and lipid peroxide content following different types of ischemia in the isolated rat heart.
Coudray C; Boucher F; Pucheu S; de Leiris J; Favier A
Agents Actions; 1994 May; 41(3-4):144-50. PubMed ID: 7942321
[TBL] [Abstract][Full Text] [Related]
16. Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis.
Wang S; Li Y; Song X; Wang X; Zhao C; Chen A; Yang P
J Transl Med; 2015 Jul; 13():209. PubMed ID: 26136232
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome p450 2C enzymes contribute to peritransplant ischemic injury and cardiac allograft vasculopathy.
Hunter AL; Kerjner A; Mueller KJ; McManus BM; Granville DJ
Am J Transplant; 2008 Aug; 8(8):1631-8. PubMed ID: 18557730
[TBL] [Abstract][Full Text] [Related]
18. Tempol reduces infarct size in rodent models of regional myocardial ischemia and reperfusion.
McDonald MC; Zacharowski K; Bowes J; Cuzzocrea S; Thiemermann C
Free Radic Biol Med; 1999 Sep; 27(5-6):493-503. PubMed ID: 10490268
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of cytochrome P450 induced by proteasome inhibition during cardiac ischemia.
Ishihara Y; Hamaguchi A; Sekine M; Hirakawa A; Shimamoto N
Arch Biochem Biophys; 2012 Nov; 527(1):16-22. PubMed ID: 22885143
[TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
